1. Clinical Overview
Loteprednol etabonate is a site-specific, soft corticosteroid (C-20 ester corticosteroid) designed for ophthalmic use. It is a prodrug that undergoes rapid hydrolysis to an inactive metabolite after exerting its therapeutic effect, minimizing systemic side effects. It is a potent anti-inflammatory agent with a high affinity for glucocorticoid receptors in ocular tissues.
| Onset | Duration | Bioavailability |
|---|---|---|
| Therapeutic anti-inflammatory effects typically begin within hours, with peak effects observed within 2-3 days of initiation. | Local duration is approximately 6-8 hours per dose, necessitating multiple daily applications for continuous effect. | Negligible systemic bioavailability (<1%) following topical ocular administration due to rapid local metabolism. |
2. Mechanism of Action
Loteprednol etabonate binds to cytoplasmic glucocorticoid receptors, forming a complex that translocates to the cell nucleus. It binds to glucocorticoid response elements (GREs) on DNA, modulating gene transcription. This leads to the induction of anti-inflammatory proteins (like lipocortin) and inhibition of the synthesis of pro-inflammatory mediators such as prostaglandins, leukotrienes, and cytokines (IL-1, IL-2, IL-6, TNF-α). It also stabilizes lysosomal membranes and inhibits macrophage migration.
3. Indications & Uses
- Treatment of post-operative inflammation following ocular surgery
- Treatment of steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe (e.g., allergic conjunctivitis, vernal keratoconjunctivitis, episcleritis, anterior uveitis)
4. Dosage & Administration
Adult Dosage: One drop (approx. 0.05 ml of 0.5% = 5mg/ml suspension) into the affected eye(s) 4 times daily. For post-operative inflammation: Begin 24 hours after surgery and continue for 2 weeks. For other inflammations: Frequency may be reduced as inflammation subsides (e.g., to twice daily). Do not discontinue abruptly.
Administration: 1. Wash hands. 2. Shake the suspension well before use. 3. Tilt head back, pull lower eyelid down to form a pouch. 4. Instill one drop without touching the dropper tip to eye or any surface. 5. Close eyes gently for 1-2 minutes, apply gentle pressure on the nasolacrimal duct (inner corner of eye) to minimize systemic absorption. 6. Wait at least 5-10 minutes before instilling any other eye drop. 7. Recap bottle tightly.
5. Side Effects
Common side effects may include:
- Transient ocular burning/stinging on instillation
- Blurred vision immediately after instillation
- Foreign body sensation
- Itching
- Dry eye
- Conjunctival hyperemia (redness)
- Watering
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Ocular Corticosteroids (e.g., Dexamethasone, Prednisolone) | Additive risk of elevated IOP, cataract formation, and infection. | Major |
| Ocular NSAIDs (e.g., Ketorolac, Nepafenac) | May increase risk of corneal adverse events (ulceration, perforation) especially post-surgery. Can be used together with monitoring. | Moderate |
| Acetazolamide, Dorzolamide, Timolol (Anti-glaucoma drugs) | Loteprednol may elevate IOP, potentially counteracting the effect of anti-glaucoma medication. Close IOP monitoring required. | Moderate |
| Cyclosporine (ophthalmic emulsion) | Potential synergistic anti-inflammatory effect. Administer at least 15 minutes apart. | Minor |
7. Patient Counselling
- DO shake the bottle well before each use.
- DO use exactly as prescribed; do not increase frequency or duration.
- DO wait at least 5-10 minutes between instilling different eye drops.
- DO apply nasolacrimal duct pressure (pressing inner corner of eye) for 1-2 minutes after instillation.
- DO attend all follow-up appointments for IOP and slit-lamp examinations.
- DON'T let the dropper tip touch your eye, fingers, or any surface.
- DON'T wear contact lenses while using this medication or if you have an active ocular infection/inflammation.
- DON'T share your eye drops with anyone.
- DON'T stop using the medication abruptly without consulting your doctor.
8. Toxicology & Storage
Overdose: Topical overdose is unlikely to cause acute systemic toxicity. Symptoms would be local: severe ocular irritation, pain, blurred vision, increased IOP. Accidental oral ingestion may lead to systemic corticosteroid effects (hyperglycemia, adrenal suppression) but is unlikely from a single bottle.
Storage: Store at controlled room temperature (15°C to 25°C). Protect from light and freezing. Keep the bottle tightly closed when not in use. Discard the bottle 4 weeks after opening it (write the discard date on the bottle). Keep out of reach and sight of children.